HoLEP is the preferred laser option across the full range of gland sizes, but its anatomical, haemostatic and size-independent properties matter most in three clinical scenarios where other prostate surgery options are limited.
HoLEP has largely replaced open simple prostatectomy for glands over 100 g, with equivalent outcomes and less bleeding.4, 5
AUA guidance identifies HoLEP as appropriate at higher bleeding risk, including men on anticoagulant or antiplatelet therapy.1, 11, 12
HoLEP for men who are catheter-dependent after acute retention or who have failed trial of void.16
HoLEP enucleates the adenoma along its natural plane with the capsule, rather than shaving it from the lumen. This produces three properties that matter in the special-situations scenarios:
You can ask for a second opinion on your symptoms, flow studies and prostate size before deciding between medication, HoLEP, GreenLight, TURP, UroLift, Rezum or iTind.